Court Place Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,882 shares of the healthcare conglomerate’s stock after purchasing an additional 223 shares during the period. UnitedHealth Group accounts for 0.8% of Court Place Advisors LLC’s holdings, making the stock its 27th biggest holding. Court Place Advisors LLC’s holdings in UnitedHealth Group were worth $2,557,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Financial Management Professionals Inc. increased its position in shares of UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after acquiring an additional 17 shares in the last quarter. Richwood Investment Advisors LLC increased its position in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after acquiring an additional 20 shares in the last quarter. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock worth $47,000 after acquiring an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock worth $1,080,000 after purchasing an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC boosted its holdings in UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
UNH has been the topic of several analyst reports. Oppenheimer cut their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research note on Wednesday, May 14th. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, Baird R W lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $307.50 on Wednesday. The firm’s 50 day simple moving average is $320.63 and its 200 day simple moving average is $444.69. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $278.95 billion, a PE ratio of 12.88, a price-to-earnings-growth ratio of 1.45 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the firm earned $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.87%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.
Insider Buying and Selling
In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the business’s stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Differences Between Momentum Investing and Long Term Investing
- Chime Financial: Analysts Ring In—And It’s a Buy
- What Does a Stock Split Mean?
- Palantir’s Revenue Surge to $1B: Growth vs. Valuation
- Using the MarketBeat Stock Split Calculator
- Alibaba Expands Data Centers Across Asia: A New Growth Catalyst?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.